Technicon immuno 1® PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis

Journal of Clinical Laboratory Analysis

Volumn 10, Issue 3, 1996, Pages 155-159

  Zhou, Zeqi ^a   Ng, Phillip C ^a   Very Jr , Donald L ^a   Allard, W Jeffrey ^a   Yeung, Kwok K ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Automated immunoassay; Prostate cancer; Sandwich immunoaseay

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; AUTOANALYSIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPLEX FORMATION; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MALE; PROSTATE CANCER; SERODIAGNOSIS;

ALPHA 1-ANTICHYMOTRYPSIN; AUTOMATION; CALIBRATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN BINDING; REGRESSION ANALYSIS;

EID: 0029940586     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2825(1996)10:3<155::aid-jcla8>3.0.co;2-a     Document Type: Article

References (27)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 17:159-163, 1979.
2. Watt WK, Lee PJ, Timkulu TM, Chan WP, Loor R: Human prostate-specific antigen: Structure and functional similarity with serine proteases. Proc Natl Acad Sci USA 83:3166-70, 1986.
3. Akiyama K, Nakamura T, Iwanaga S, Hara M: The chymotrypsin-like activity of human prostate-specific antigen, γ-seminoprotein. FEBS Lett 225:168-72, 1987.
4. Christensson A, Laurel CB, Lilja H: Enzymatic activity of prostatic-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Brochem 194:755-763, 1990.
5. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76:1899-903, 1985.
6. Lilja H, Abrahamsson PA: Three predominant proteins secreted by the human prostate gland. Prostate 12:29-38, 1980.
7. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM: A prostate antigen in sera of prostate cancer patients. Cancer Res 40:2428-2432, 1980.
8. Lange PH: Prostate specific antigen in diagnosis and management of prostate cancer. Urology (suppl.) 36:25-29, 1990.
9. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.J Urol 145:907-923, 1991.
10. Armbruster DA: Prostate-specific antigen: Biochemistry, analytical methods and clinical application. Clin Chem 39:181-195, 1993.
11. American Cancer Society: Cancer Facts & Figures - 1995. American Cancer Society, Atlanta, p 11.
12. Stenman UH, Leinonen J,Alfthan H, Rannikko S,Tuhkanen K, Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer Assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222-226, 1991.
13. Zhou AM, Tewari PC, Bluestein BL, Caldwell GW, Larsen FL: Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 39:2483-2491, 1993.
14. Leinonen J, Lovgren T, Vomanen T, Stenman UH: Double-label time-resolved immunofluorometric assay of prostate-specific antigen and its complex with alpha-1-antichymotrypsin. Clin Chem 39:2098-2103, 1993.
15. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, Abrahamsson P-A. Lilja H: Serum prostate specific antigen complexed with alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 150:100-105, 1993.
16. Lilja H: Significance of different molecular forms of serum PSA: The free, noncomplexed forms of PSA versus that complexed to alpha-1-antichymotrypsin. Urol Clin North Am 20:681-686, 1993.
17. Lilja H, Christensson A, Dahlen U, Matikainen M-T, Nilsson O, Pettersson K, Lovgren T: Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 37:1618-1625, 1991.
18. Bjork T, Hulkko S, Bjartell A, Santagnese AD, AbrahamssonP-A, Lilja H:Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 43:427-434, 1994.
19. Stamey TA: Second Stanford conferences on international standardization of prostate specific antigen immunoassays: September 1 and 2, 1994. Urology 45:173-184, 1995.
20. Smith AJ, Scaletsky R: Future directions in tumor marker technology for prostate cancer. Urol Clin North Am 20:771-777, 1993.
21. Graves HCB, Wehener N, Stamey TA: Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international antigen standard. J Urol 144:1516-1522, 1990.
22. Rippey JH, Wener MH, Horoszewicz J, Stenman U-H, Klee GG, Bekanger A, Maxim PE, Graves H, Howanitz J, Nakamura RM: Workgroup #1: Standardization of PSA. Cancer 71:2678, 1993.
23. Technicon Immuno 1 PSA Assay Instructions, Bayer Diagnostics. Clinical Method (DA4-1207F94), June 1994, issued, 1994.
24. Wu JT: Assays for prostate specific antigen (PSA): problems and possible solutions. J Clin Lab Anal 8:51-62, 1994.
25. Strobel SA, Sokoloff RL, Wolfert RL, Rittenhouse HG: Multiple forms of prostate-specific antigen in serum measured differently in equimolar- and skewed-response assays. Clin Chem 41:125-126, 1995.
26. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh P: Prostate specific antigen as a marker for prostate cancer: A monoclonal and a polyclonal immunoassay compared. Clin Chem 33:1916-1920, 1987.
27. Horton GL. Bahnson RR, Draft M, Chen K-M, Catalona WJ, Ladenson JH: Differences in values obtained with 2 assays of prostate specific antigen. J Urol 139.762, 1988.